PaxMedica Inc Stock Skyrockets on Breakthrough Autism Study
In a groundbreaking development, clinical-stage biopharmaceutical company PaxMedica Inc saw its stock surge by an unprecedented 175% to $8.39 on Tuesday morning following the release
Home
Page 393
Alto Ingredients Reports Q3 2023 Financial Results: Sees Stock Downturn
Alto Ingredients, a prominent producer and distributor of specialty alcohols and essential ingredients, disclosed its financial results for the third quarter (Q3) concluding on September
Ventyx Biosciences Stock Takes Major Hit on Phase 2 Results
San Diego-based clinical-stage biopharmaceutical firm, Ventyx Biosciences, unveiled pivotal findings from the Phase 2 clinical trial of VTX958, targeted at patients grappling with moderate to
Stock of Matinas BioPharma Soars on Promising Oral LNC Docetaxel Results
Matinas BioPharma Holdings, a clinical-stage biopharmaceutical company specializing in revolutionary therapies utilizing its lipid nanocrystal (LNC) platform technology, has disclosed encouraging outcomes from an in
Q4 Projections of Uber Hint at Strong Year-End Finish, Stocks Decline
Ride-hailing and food delivery company Uber Technologies (UBER) announced on Tuesday its projections of fourth-quarter (Q4) gross bookings and adjusted core profit surpassing market expectations.
Investors Tread Cautiously as Wall Street Presents Mixed Stocks
Wall Street experienced a mixed morning on Tuesday, with stocks wavering on both sides of the flatline. Despite renewed confidence in the Federal Reserve’s decision
Monday’s Trading Session Ends with Marginal Stocks’ Fluctuations
In a capricious trading session, stocks experienced marginal fluctuations on Monday, capping off their most impressive week of the year. Optimism persisted that the Federal
Small Business Owners Grapple with Surge in Prices Amid Persistent Inflation
Small business proprietors are grappling with the relentless surge in prices of essential goods, as inflation maintains its grip on the economy. The Make Your
Global Logistics Difficulties Hit 26-Year Low, Federal Reserve Bank of New York Reports
Global logistics difficulties have reached their lowest point in more than a quarter-century, as revealed by the Federal Reserve Bank of New York’s Global Supply
Russell 2000 Index Marks Strongest Week in Over Two Years
In a notable surge, the Russell 2000 index (^RUT) experienced its most robust performance in more than two years, reflecting a renewed investor confidence in
